iShares Biotechnology ETF
IBB
IBB
597 hedge funds and large institutions have $5.25B invested in iShares Biotechnology ETF in 2019 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 128 increasing their positions, 269 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
597
Holders Change
-49
Holders Change %
-7.59%
% of All Funds
13.11%
Holding in Top 10
9
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-35.71%
% of All Funds
0.2%
New
49
Increased
128
Reduced
269
Closed
96
Calls
$509M
Puts
$707M
Net Calls
-$199M
Net Calls Change
+$100M
Top Buyers
| 1 |
1
Barclays
London,
United Kingdom
|
$315M |
| 2 |
2
Citigroup
New York
|
$382M |
| 3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$205M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$178M |
| 5 |
5
Goldman Sachs
New York
|
$273M |
